User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study Group.

  1. Alberti Kgmm, Diabetic Med., 11, 899 (1994)
  2. Hermann L. S., Biguanides and Sulfonylureas as Combination Therapy in NIDDM, 10.2337/diacare.13.3.37
  3. Kumar S., Boulton A. J. M., Beck-Nielsen H., Berthezene F., Muggeo M., Persson B., Spinas G. A., Donoghue S., Lettis S., Stewart-Long P., Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients, 10.1007/s001250050498
  4. Leutenegger Marc, Sacca Luigi, Alderton Claire, Eckland David, Lettis Sally, Double-masked, placebo-controlled, dose-ranging study of troglitazone 10 to 200 mg once daily in non—insulin-dependent diabetes mellitus, 10.1016/s0011-393x(97)80031-8
  5. Schwartz Sherwyn, Raskin Philip, Fonseca Vivian, Graveline Jane F., Effect of Troglitazone in Insulin-Treated Patients with Type II Diabetes Mellitus, 10.1056/nejm199803263381302
  6. Inzucchi Silvio E., Maggs David G., Spollett Geralyn R., Page Stephanie L., Rife Frances S., Walton Veronika, Shulman Gerald I., Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus, 10.1056/nejm199803263381303
  7. Fujiwara T, Diabetes., 37, 1549 (1988)
  8. Fujiwara T, Metabolism., 44, 486 (1995)
  9. Levin K, Endocrinol Metab., 4, 255 (1997)
  10. Lehmann S., Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrP^C, in Cultured Cells, 10.1074/jbc.270.50.30221
  11. Lenhard James M, Kliewer Steven A, Paulik Mark A, Plunket Kelli D, Lehmann Jurgen M, Weiel James E, Effects of troglitazone and metformin on glucose and lipid metabolism, 10.1016/s0006-2952(97)00229-3
  12. Groop LC., Diabetes Care., 15, 737 (1992)
  13. 13 MA Young, Dja Eckland, R Eastmond, and S. Lettis Establishing the dose response curve for metabolic control with troglitazone, an insulin action enhancer, in type 2 diabetes patients.Ann Med.; 1998 , 1998 , 1998 .
  14. Ghazzi M, Diabetes., 46 (1997)
  15. Correa Jcn, Eur J Clin Res., 9, 151 (1997)
Bibliographic reference Buysschaert, Martin ; Bobbioni, E ; Starkie, M ; Frith, L. Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone. Troglitazone Study Group.. In: Diabetic medicine : a journal of the British Diabetic Association, Vol. 16, no. 2, p. 147-53 (1999)
Permanent URL http://hdl.handle.net/2078.1/8267